• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    SS Innovations Appoints Naveen Kumar Amar as Chief Financial Officer

    9/26/25 8:30:00 AM ET
    $SSII
    Medical/Dental Instruments
    Health Care
    Get the next $SSII alert in real time by email

    FORT LAUDERDALE, Fla., Sept. 26, 2025 (GLOBE NEWSWIRE) -- SS Innovations International, Inc. (the "Company" or "SS Innovations") (NASDAQ: SSII), a developer of innovative surgical robotic technologies dedicated to making robotic surgery affordable and accessible to a global population, today announced the appointment of Naveen Kumar Amar as the Company's Chief Financial Officer, effective September 24, 2025. Mr. Amar is assuming the Chief Financial Officer role, on a permanent basis, from Dr. Vishwa Srivastava, who has served as the Company's Interim Chief Financial Officer since July 2025. Dr. Vishwa Srivastava will continue in his capacity as the Company's Chief Executive Officer – Asia Pacific.

    Mr. Amar brings to SS Innovations more than 25 years of global finance leadership experience spanning a wide range of industries and geographies. During his career, he has amassed expertise in financial accounting and reporting, planning and analysis, budgeting, forecasting, corporate finance, treasury operations, governance, internal controls, and both U.S. and Indian GAAP, among other areas. He has been recognized as one of India's top financial executives by various publications and organizations, including Forbes India magazine, Forbes Asia magazine, CFO India Forum, and Chartered Institute of Management Accountants, London.

    Dr. Sudhir Srivastava, Chairman of the Board and Chief Executive Officer of SS Innovations, commented, "Amar brings to SS Innovations a strong track record of building best-in-class finance operations, effective cross-functional teams, and successful businesses across diverse industries and geographies. We are thrilled to welcome a seasoned financial executive of his caliber to our leadership team as we expand the global presence of our advanced, cost-efficient SSi Mantra surgical robotic system."

    Mr. Amar added, "I am honored to be joining SS Innovations at this exciting stage in its journey to democratize access to advanced surgical robotic care and I look forward to helping the team drive growth and deliver sustainable long-term shareholder value."

    Most recently, Mr. Amar has provided virtual CFO services to clients based in the United States, Canada and the United Kingdom. Among his previous positions, Mr. Amar served as Head of Finance & Commercial for SpiceXpress, the cargo division of SpiceJet; Global CFO for Munch Ado India Private Ltd., a software enterprise technology provider; Senior Vice President – Finance & Compliance and Company Secretary for MSD Wellcome Trust Hilleman Laboratories Private Ltd., a global vaccine manufacturer; Chief Financial Officer – India & Australia and Company Secretary for EDirect Proprietary Ltd., a telecommunications provider; and India Manager – Financial Consolidation and Company Secretary for GE India.

    Mr. Amar graduated with a Bachelor of Commerce degree from the University of Delhi and received a post graduate diploma in Business Management from All India Management Association's Centre of Management Education. In addition, he earned the Chartered Accountant designation from the Institute of Chartered Accountants of India as well as the Company Secretary designation from the Institute of Company Secretaries of India.

    About SS Innovations

    SS Innovations International, Inc. (NASDAQ: SSII) develops innovative surgical robotic technologies with a vision to make the benefits of robotic surgery affordable and accessible to a larger segment of the global population. The Company's product range includes its proprietary "SSi Mantra" surgical robotic system and its comprehensive suite of "SSi Mudra" surgical instruments, which support a variety of surgical procedures including robotic cardiac surgery. An American company headquartered in India, SS Innovations plans to expand the global presence of its technologically advanced, user-friendly, and cost-effective surgical robotic solutions. Visit the Company's website at ssinnovations.com or LinkedIn for more information and updates.

    About the SSi Mantra

    The SSi Mantra surgical robotic system is a user-friendly, modular, multi-arm system with many advanced technology features, including: 3 to 5 modular robotic arms, an open-faced ergonomic surgeon command center, a large 3D 4K monitor, a touch panel monitor for all patient related information display, a virtual real-time image of the robotic patient side arm carts, and the ability for superimposition of 3D models of diagnostic imaging. A vision cart provides the table-side team with the same magnified 3D 4K view as the surgeon to provide better safety and efficiency. The SSi Mantra utilizes over 40 different types of robotic endo-surgical instruments to support different specialties, including cardiac surgery. The SSi Mantra has been clinically validated in India in more than 100 different types of surgical procedures.

    Forward Looking Statements

    This press release may contain statements that are not historical facts and are considered forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995. The words "anticipate," "assume," "believe," "estimate," "expect," "will," "intend," "may," "plan," "project," "should," "could," "seek," "designed," "potential," "forecast," "target," "objective," "goal," or the negatives of such terms or other similar expressions to identify such forward-looking statements. These statements relate to future events or SS Innovations' future financial performance and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance, or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements.

    Investor Contact:

    The Equity Group

    Kalle Ahl, CFA

    T: (303) 953-9878

    [email protected]

    Devin Sullivan, Managing Director

    T: (212) 836-9608

    [email protected]

    Media Contact:

    RooneyPartners LLC

    Kate Barrette

    T: (212) 223-0561

    [email protected]



    Primary Logo

    Get the next $SSII alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $SSII

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $SSII
    SEC Filings

    View All

    SS Innovations International Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits

    8-K - SS Innovations International, Inc. (0001676163) (Filer)

    9/26/25 8:30:36 AM ET
    $SSII
    Medical/Dental Instruments
    Health Care

    SS Innovations International Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

    8-K - SS Innovations International, Inc. (0001676163) (Filer)

    9/16/25 8:30:27 AM ET
    $SSII
    Medical/Dental Instruments
    Health Care

    SS Innovations International Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

    8-K - SS Innovations International, Inc. (0001676163) (Filer)

    9/9/25 8:30:29 AM ET
    $SSII
    Medical/Dental Instruments
    Health Care

    $SSII
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    SS Innovations Appoints Naveen Kumar Amar as Chief Financial Officer

    FORT LAUDERDALE, Fla., Sept. 26, 2025 (GLOBE NEWSWIRE) -- SS Innovations International, Inc. (the "Company" or "SS Innovations") (NASDAQ: SSII), a developer of innovative surgical robotic technologies dedicated to making robotic surgery affordable and accessible to a global population, today announced the appointment of Naveen Kumar Amar as the Company's Chief Financial Officer, effective September 24, 2025. Mr. Amar is assuming the Chief Financial Officer role, on a permanent basis, from Dr. Vishwa Srivastava, who has served as the Company's Interim Chief Financial Officer since July 2025. Dr. Vishwa Srivastava will continue in his capacity as the Company's Chief Executive Officer – Asia

    9/26/25 8:30:00 AM ET
    $SSII
    Medical/Dental Instruments
    Health Care

    SS Innovations Announces Successful Completion of World's First Pediatric Pyeloplasty Telesurgery Utilizing the Company's SSi Mantra Surgical Robotic System

    FORT LAUDERDALE, Fla., Sept. 16, 2025 (GLOBE NEWSWIRE) --  SS Innovations International, Inc. (the "Company" or "SS Innovations") (NASDAQ:SSII), a developer of innovative surgical robotic technologies dedicated to making robotic surgery affordable and accessible to a global population, today announced that the world's first pediatric pyeloplasty telesurgery has been successfully performed utilizing the Company's SSi Mantra surgical robotic system. Dr. Chandra Mohan Vaddi, Managing Director of Preeti Urology & Kidney Hospitals ("Preeti Hospital"), completed the robotic procedure remotely from SS Innovations' headquarters in Gurugram, India, nearly 1,000 miles away from a 16-month-old patien

    9/16/25 8:30:00 AM ET
    $SSII
    Medical/Dental Instruments
    Health Care

    SS Innovations Announces Successful Completion of First Robotic Telesurgery Performed from the Company's MantraM Mobile Robotic Telesurgery Unit

    FORT LAUDERDALE, Fla., Sept. 09, 2025 (GLOBE NEWSWIRE) -- SS Innovations International, Inc. (the "Company" or "SS Innovations") (NASDAQ:SSII), a developer of innovative surgical robotic technologies dedicated to making robotic surgery affordable and accessible to a global population, today announced the successful completion of the first robotic telesurgery performed from the Company's MantraM mobile robotic telesurgery unit (the "MantraM bus"). Dr. Priya Bhave Chittawar, Founder and Managing Director of Harmony Institute of Excellence in Reproductive Health ("HER Health"), guided a complex hysterectomy remotely from the MantraM bus utilizing the Company's SSi Mantra surgical robotic syst

    9/9/25 8:30:00 AM ET
    $SSII
    Medical/Dental Instruments
    Health Care

    $SSII
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chairman and CEO Srivastava Sudhir received a gift of 2,500 shares and gifted 105,000 shares (SEC Form 4)

    4 - SS Innovations International, Inc. (0001676163) (Issuer)

    9/8/25 4:30:12 PM ET
    $SSII
    Medical/Dental Instruments
    Health Care

    Chairman and CEO Srivastava Sudhir gifted 111,000 shares and received a gift of 60,000 shares (SEC Form 4)

    4 - SS Innovations International, Inc. (0001676163) (Issuer)

    8/13/25 5:53:10 PM ET
    $SSII
    Medical/Dental Instruments
    Health Care

    COO - Americas Cohen Barry F gifted 1,000,000 shares, decreasing direct ownership by 11% to 7,866,888 units (SEC Form 4)

    4 - SS Innovations International, Inc. (0001676163) (Issuer)

    6/30/25 7:06:03 PM ET
    $SSII
    Medical/Dental Instruments
    Health Care

    $SSII
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Amendment: COO - Americas Cohen Barry F bought $3,799 worth of shares (426 units at $8.92), increasing direct ownership by 0.00% to 8,866,888 units (SEC Form 4)

    4/A - SS Innovations International, Inc. (0001676163) (Issuer)

    6/30/25 6:55:24 PM ET
    $SSII
    Medical/Dental Instruments
    Health Care

    $SSII
    Leadership Updates

    Live Leadership Updates

    View All

    SS Innovations Appoints Naveen Kumar Amar as Chief Financial Officer

    FORT LAUDERDALE, Fla., Sept. 26, 2025 (GLOBE NEWSWIRE) -- SS Innovations International, Inc. (the "Company" or "SS Innovations") (NASDAQ: SSII), a developer of innovative surgical robotic technologies dedicated to making robotic surgery affordable and accessible to a global population, today announced the appointment of Naveen Kumar Amar as the Company's Chief Financial Officer, effective September 24, 2025. Mr. Amar is assuming the Chief Financial Officer role, on a permanent basis, from Dr. Vishwa Srivastava, who has served as the Company's Interim Chief Financial Officer since July 2025. Dr. Vishwa Srivastava will continue in his capacity as the Company's Chief Executive Officer – Asia

    9/26/25 8:30:00 AM ET
    $SSII
    Medical/Dental Instruments
    Health Care

    SS Innovations Announces Chief Financial Officer Transition

    FORT LAUDERDALE, Fla., May 02, 2025 (GLOBE NEWSWIRE) -- SS Innovations International, Inc. (the "Company" or "SS Innovations") (NASDAQ:SSII), a developer of innovative surgical robotic technologies dedicated to making robotic surgery affordable and accessible to a global population, today announced the appointment of Arvind Palaniappan as the Company's Interim Chief Financial Officer, effective May 1, 2025, pursuant to a planned leadership transition. Anup Sethi, SS Innovations' departing CFO, will remain available to advise the Company prior to the appointment of a permanent CFO.   SS Innovations has commenced a search process to identify and recruit a permanent successor for the CFO role

    5/2/25 8:30:00 AM ET
    $SSII
    Medical/Dental Instruments
    Health Care